Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Corticosteroids for IRIS in Natalizumab-Associated PML
NCT01211665Phase 4Terminated
- Sponsor
- Biogen
- Start
- Sep 2010
- Primary completion
- Feb 2012
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 4 trial of methylprednisolone injection in immune reconstitution inflammatory syndrome (IRIS), sponsored by Biogen. Started Sep 2010; status: terminated.
02
Drugs
methylprednisolone injection
03
Conditions
immune reconstitution inflammatory syndrome (IRIS)
Beyond the preview
Go deeper on NCT01211665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01211665.